跳至主要内容
临床试验/NCT02140970
NCT02140970已完成不适用

Double-blind, Placebo-controlled Randomized Controlled Trial of NSAID Prior to Ureteral Stent Removal in a Pediatric Population

University of Colorado, Denver1 个研究点 分布在 1 个国家目标入组 51 人开始时间: 2014年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
51
试验地点
1
主要终点
Incidence of Post-operative Severe Pain (Pain Score ≥ 7)

研究概览

简要总结

This study plans to learn more about whether ibuprofen can reduce pain after removal of a ureteral stent more than a placebo. Some patients experience pain after removal of a ureteral stent. The investigators plan to learn how often this occurs and whether it can be prevented.

The investigators hypothesize that children who have a temporary, indwelling ureteral stent will experience a significantly less post-operative pain if given a non-steroidal anti-inflammatory (NSAID) prior to removal of the ureteral stent when compared to placebo. The investigators hypothesize that the incidence of severe post-stent removal pain is similar to an adult population.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
4 Years 至 17 Years(Child)
性别
All
接受健康志愿者

入选标准

  • ages 4-17
  • unilateral ureteral stent placed after ureteropelvic junction obstruction repair or treatment of upper tract urolithiasis

排除标准

  • bilateral stents
  • undergoing other concomitant procedure at time of planned ureteral stent removal
  • indication for stent other than ureteropelvic junction obstruction repair or treatment of upper tract urolithiasis
  • developmental delay
  • allergy to ibuprofen or non-steroidal anti-inflammatory medication class
  • chronic kidney disease
  • prior renal transplant
  • history of nasal polyps
  • history of asthma

研究组 & 干预措施

Liquid ibuprofen

Experimental

10 mg/kg orally up to a maximum of 400 mg given once at least 15 minutes prior to ureteral stent removal

干预措施: Ibuprofen (Drug)

Liquid placebo

Placebo Comparator

Similar-tasting and appearing liquid placebo of equal volume to be given once orally at least 15 minutes prior to ureteral stent removal

干预措施: Placebo (Drug)

结局指标

主要结局

Incidence of Post-operative Severe Pain (Pain Score ≥ 7)

时间窗: 24 hours after stent removal

Two pain scales were used (Faces pain scale-revised \[FPS-R\] and visual analogue scale \[VAS\]) and converted to continuous value 0-10.

次要结局

  • Incidence of "Significantly Worsening" Pain(24 hours after stent removal)
  • Change in Pre- and Post-operative Pain Score(24 hours after stent removal)
  • Opioid Usage Post-operatively(24 hours after stent removal)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Randomized Trial of NSAID vs Placebo Prior to... | 临床试验